XML 52 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Plans and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Option Activity Includes Options Granted

The following table, which includes options granted under the Company’s Stock Plans, summarizes option activity:

 

 

 

Shares

Subject to

Outstanding

Options

 

 

Weighted

Average

Exercise

Price Per

Share

 

 

Weighted

Average

Remaining

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic

Value

(in thousands)

 

Outstanding at December 31, 2019

 

 

4,738,004

 

 

$

9.00

 

 

 

 

 

 

 

 

 

Options granted

 

 

5,784,550

 

 

$

17.36

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(392,523

)

 

$

8.54

 

 

 

 

 

 

 

 

 

Options forfeited or canceled

 

 

(237,334

)

 

$

10.38

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

9,892,697

 

 

$

13.88

 

 

 

8.81

 

 

$

122,232

 

Options vested and expected to vest as of December 31,

   2020

 

 

9,892,697

 

 

$

13.88

 

 

 

8.81

 

 

$

122,232

 

Options exercisable as of December 31, 2020

 

 

2,793,050

 

 

$

10.28

 

 

 

8.12

 

 

$

44,012

 

Summary of Restricted Stock Units Activity

The Company granted restricted stock units (RSUs) to its employees and directors under the 2018 Plan. The shares subject to the RSUs vest annually or quarterly over four years for employees and annually for directors.

 

 

 

Total Restricted Stock Units

 

 

Weighted

Average

Grant Date Fair Value

 

Nonvested at December 31, 2019

 

 

-

 

 

$

-

 

RSUs granted

 

 

758,950

 

 

 

27.77

 

RSUs vested

 

 

(6,250

)

 

 

17.00

 

RSUs forfeited or canceled

 

 

(14,050

)

 

 

29.05

 

Nonvested at December 31, 2020

 

 

738,650

 

 

$

27.84

 

Summary of Employee and Non-Employee Stock-based Compensation Expense

The following table summarizes employee and non-employee stock-based compensation expense for the years ended December 31, 2020, 2019 and 2018, and also the allocation within the consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Research and development

 

$

11,195

 

 

$

4,152

 

 

$

2,255

 

General and administrative

 

 

10,630

 

 

 

4,829

 

 

 

1,619

 

Total stock-based compensation

 

$

21,825

 

 

$

8,981

 

 

$

3,874

 

Schedule of Assumptions Used to Calculate Fair Value of Stock-Based Compensation The following assumptions were used to calculate the fair value of stock-based compensation for the years ended December 31, 2020, 2019, and 2018:

 

 

 

Stock Options

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Risk-free interest rate

 

0.4% - 0.5%

 

 

1.6% - 2.3%

 

 

1.2% - 3.1%

 

Expected term (in years)

 

6.02

 

 

6.02

 

 

5.16-9.95

 

Volatility

 

76.5% - 78.5%

 

 

71.8% - 74.6%

 

 

58.7%-75.5%

 

Dividend yield

 

0%

 

 

0%

 

 

0%

 

 

 

 

 

ESPP

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Risk-free interest rate

 

0.1% - 0.2%

 

 

1.6% - 2.3%

 

 

2.1% - 2.6%

 

Expected term (in years)

 

0.5-2.0

 

 

0.5-2.0

 

 

0.5-2.0

 

Volatility

 

66.6% - 136.0%

 

 

64.8% - 77.1%

 

 

54.3% - 65.5%

 

Dividend yield

 

0%

 

 

0%

 

 

0%